Inspire Corporate Bond ETF (NYSEARCA:IBD – Get Free Report) rose 0.8% on Monday . The stock traded as high as $23.77 and last traded at $23.74. Approximately 45,821 shares were traded during mid-day trading, a decline of 47% from the average daily volume of 85,718 shares. The stock had previously closed at $23.56.
Inspire Corporate Bond ETF Stock Performance
The business has a 50 day moving average price of $23.83 and a 200-day moving average price of $23.71.
Hedge Funds Weigh In On Inspire Corporate Bond ETF
Large investors have recently modified their holdings of the stock. EverSource Wealth Advisors LLC lifted its position in Inspire Corporate Bond ETF by 343.7% during the second quarter. EverSource Wealth Advisors LLC now owns 49,029 shares of the company’s stock worth $1,160,000 after purchasing an additional 37,979 shares during the period. Vicus Capital raised its position in Inspire Corporate Bond ETF by 12.3% during the third quarter. Vicus Capital now owns 69,130 shares of the company’s stock valued at $1,665,000 after purchasing an additional 7,577 shares in the last quarter. Finally, Creative Financial Designs Inc. ADV lifted its stake in Inspire Corporate Bond ETF by 20.3% during the third quarter. Creative Financial Designs Inc. ADV now owns 667,785 shares of the company’s stock worth $16,080,000 after purchasing an additional 112,635 shares during the last quarter.
Inspire Corporate Bond ETF Company Profile
The Inspire Corporate Bond Impact ESG ETF (IBD) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks an equally weighted index of bonds issued by S&P 500-component companies that meet biblically responsible investing standards according to the Issuer. IBD was launched on Jul 10, 2017 and is managed by Inspire.
Recommended Stories
- Five stocks we like better than Inspire Corporate Bond ETF
- Breakout Stocks: What They Are and How to Identify Them
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Inspire Corporate Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Corporate Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.